FKS2 and FKS3 Genes of Opportunistic Human Pathogen Candida albicans Influence Echinocandin Susceptibility

The Candida albicans transcription factor Cas5 couples stress responses, drug resistance and cell cycle regulation

(2017) Jinglin L. Xie et al.   Nature Communications

Candida albicans orf19.3727 encodes phytase activity and is essential for human tissue damage

(2017) Paul Wai-Kei Tsang et al.   PLoS One

Chromosome 5 of human pathogenCandida albicanscarries multiple genes for negative control of caspofungin and anidulafungin susceptibility

(2016) Sumanun Suwunnakorn et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

(2016) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Exploiting mitochondria as targets for the development of new antifungals

(2016) Dongmei Li et al.   Virulence

Mechanisms of echinocandin antifungal drug resistance

(2015) David S. Perlin   Annals of the New York Academy of Sciences

Genomic profiling of fungal cell wall-interfering compounds: identification of a common gene signature

(2015) Raúl García et al.   BMC GENOMICS

Global trends in the distribution of Candida species causing candidemia

(2014) J. Guinea   CLINICAL MICROBIOLOGY AND INFECTION

Echinocandin resistance

(2014) Maiken C. Arendrup et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Chromosome 5 Monosomy of Candida albicans Controls Susceptibility to Various Toxic Agents, Including Major Antifungals

(2013) Feng Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

(2013) Barbara D. Alexander et al.   CLINICAL INFECTIOUS DISEASES

Fks1 and Fks2 Are Functionally Redundant but Differentially Regulated in Candida glabrata: Implications for Echinocandin Resistance

(2012) Santosh K. Katiyar et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Topological and Mutational Analysis of Saccharomyces cerevisiae Fks1

(2012) Michael E. Johnson et al.   EUKARYOTIC CELL

New Fks Hot Spot for Acquired Echinocandin Resistance inSaccharomyces cerevisiaeand Its Contribution to Intrinsic Resistance ofScedosporiumSpecies

(2011) Michael E. Johnson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Current perspectives on echinocandin class drugs

(2011) David S Perlin   Future Microbiology

Defining transcribed regions using RNA-seq

(2010) Brian T Wilhelm et al.   Nature Protocols

Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints

(2008) G. Garcia-Effron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Chromosome instability and unusual features of some widely used strains ofCandida albicans

(2008) Ausaf Ahmad et al.   YEAST